Choose Your Single Pen Dose - Order Today
Single Pen Pricing - All Doses Available
Our single pen option gives you flexibility to start your weight management journey or continue at your prescribed dose. All Mounjaro single pens are prescription-only and include clinical assessment:
2.5mg Single Pen: £169.99 (£129.99 first order with FIRST40)
5mg Single Pen: £199.99 (£159.99 first order)
7.5mg Single Pen: £249.99 (£209.99 first order)
10mg Single Pen: £209.99 (£229.99 first order)
12.5mg Single Pen: £299.99 (£259.99 first order)
15mg Single Pen: £318.99 (£278.99 first order)
Why Choose Single Pen Option
Perfect for testing tolerance, trying a new dose, or if you only need one pen to complete your treatment cycle. Our single pen service includes full clinical assessment, prescription, and fast delivery to your location. Each pen contains four weekly doses of tirzepatide, designed to support weight management alongside reduced-calorie diet and increased physical activity.
Fast Local Delivery Service
We deliver nationwide with tracking provided for every order. Standard delivery takes 2-3 working days after prescription approval, or upgrade to express delivery for next-day service. All orders are discretely packaged and require signature on delivery.
Complete Clinical Service Included
Every single pen purchase includes comprehensive clinical assessment by our qualified prescribers. We review your medical history, current medications, and weight management goals to ensure Mounjaro is suitable for you. Our GPhC-registered pharmacy ensures all prescriptions meet MHRA safety standards.
Order Your Single Pen Today
Ready to start? Select your required dose above and complete our secure checkout. New customers automatically receive £40 off with code FIRST40, and returning customers save £25 on every order. Clinical assessment takes 24-72 hours, with express options available.
Questions about dosing? Our clinical team can advise on the most appropriate starting dose during your consultation. Most patients begin with 2.5mg and may progress based on clinical response and tolerance.
